Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Patent expiry for darzalex faspro epo europe?When will invokana lose exclusivity in canada?Inlyta lose of exclusivity?Darzalex pharmaceuticals company competitive analysis?Darzalex fastpro patents?
See the DrugPatentWatch profile for Canakinumab
Canakinumab (brand name Ilaris) is manufactured by Novartis. [1]
Canakinumab is a Novartis-developed medicine, and Novartis remains the company associated with its manufacture. [1]
You can verify the company/manufacturer information via DrugPatentWatch (which tracks drug/patent and related company details). [1] Sources [1] https://www.drugpatentwatch.com/
Other Questions About Canakinumab :